Search for Clinical Trial Results
Adult T-cell Leukemia/lymphoma - 89 Studies Found
Status | Study |
Completed |
Study Name: Lenalidomide in HTLV-1 Adult T-Cell Leukemia Condition: Adult T Cell Leukemia/Lymphoma Date: 2011-01-10 Interventions: Drug: Lenalidomide 25mg or 10mg (based on creatinine clearance) once daily for days 1-21 of a 28 day cyc |
Completed |
Study Name: A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma Condition:
|
Active, not recruiting |
Study Name: KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) Condition: Adult T-cell Leukemia-Lymphoma Date: 2012-06-19 Interventions:
|
Active, not recruiting |
Study Name: Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia Condition: Adult T-Cell Leukemia (ATL) Date: 2009-06-17 Interventions:
|
Completed |
Study Name: Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma Condition: Adult T-cell Leukemia-lymphoma Date: 2009-06-09 Interventions: Biological: KW-0761 KW-0761 is administered weekly for 8 weeks as an intravenous infusion of 2 hours at |
Active, not recruiting |
Study Name: A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma Condition: Adult T-Cell Leukemia-Lymphoma Date: 2012-11-07 Interventions: Drug: Lenalidomide 25 mg of Lenalidomide administered orally once daily |
Active, not recruiting |
Study Name: Evaluation and Treatment of Tall Statured Girls Condition: Constitutional Tall Stature Date: 2015-12-13 Interventions: Drug: Estradiol Estradiol containing compounds administered orally in a non-randomized manner. |
Completed |
Study Name: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) Condition: HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) Date: 2011-08-16 Interventions: Drug: CHOP-daclizumab Other Name: CHOP-Zenapax |
Recruiting |
Study Name: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma Condition:
Date: 2016-04-10 Interventions:
|
Recruiting |
Study Name: Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL) Condition: Adult T-Cell Lymphoma (ATL) Date: 2016-11-01 Interventions: Drug: HBI-8000 Oral, twice weekly |